The genes encoding microRNAs of the human miR-200 family map to fragile chromosomal regions and are frequently downregulated upon tumor progression. Although having been reported to regulate epithelial-tomesenchymal transition and transforming growth factorbeta-driven cell invasion, the role of the miR-200 family in EGF-driven breast cancer cell invasion, viability, apoptosis and cell cycle progression is still unknown. In particular, there is no study comparing the roles of the two clusters of this miRNA family. In this study, we show for the first time that miR-200 family members differentially regulate EGF-driven invasion, viability, apoptosis and cell cycle progression of breast cancer cells. We showed that, all miR-200 family members regulate EGFdriven invasion, with the miR-200bc/429 cluster showing stronger effects than the miR-200a/141 cluster. Furthermore, expression of the miR-200a/141 cluster results in G1 arrest supported by increased p27/Kip1 and decreased cyclin dependent kinase 6 expression. In contrast, expression of the 200bc/429 cluster decreases G1 population and increases G2/M phase, in line with the observed reduction of p27/Kip1 and upregulation of the inhibitory phosphorylation of Cdc25C, respectively. To test the hypothesis that phenotypical differences observed between the two clusters are caused by differential targeting spectrums, we performed genome-wide microarray profiling in combination with gain-of-function studies. This identified phospholipase C gamma 1 (PLCG1), which was downregulated only by the miR-200bc/429 cluster, as a potential candidate contributing to these phenotypical differences. Luciferase reporter assays validated PLCG1 as a direct functional target of miR-200bc/429 cluster, but not of miR-200a/141 cluster. Finally, loss of PLCG1 in part mimicked the effect of miR-200bc/429 overexpression in viability, apoptosis and EGF-driven cell invasion of breast cancer cells. Our results suggest that the miR-200 family has a tumor-suppressor function by negatively regulating EGF-driven cell invasion, viability and cell cycle progression in breast cancer.
Introduction
Breast cancer ranks first among the causes of incidence of cancers among women worldwide with about one million new cases every year, and also the most frequent cause of cancer mortality in women (Parkin et al., 2005) . It is becoming more and more evident that abnormal expression of microRNAs (miRNAs), a class of small non-coding RNAs of 20-22 nucleotides in length, is associated with a variety of human cancers including breast cancer, and that they have crucial roles in cell proliferation, differentiation and apoptosis (EsquelaKerscher and Slack, 2006; Bartel, 2009 ). Several miRNAs have been shown to be involved in the regulation of the invasive and metastasizing phenotype of breast cancer cells. For instance, miR-10b initiates tumor invasion and distal metastases in vivo (Ma et al., 2007) , whereas tumor suppressor miRNAs, such as miR-335, have also been reported, which inhibit breast cancer invasion and metastasis (Tavazoie et al., 2008) . Similarly, several miRNAs have been reported to regulate cell proliferation by modulating cell cycle progression or apoptosis by targeting key intermediates. For example, the miR-15a/16 cluster was shown to induce cell cycle arrest at G1 phase by targeting cyclin D1/D3, cyclin E1 and cyclin-dependent kinase 6 (CDK6) (Liu et al., 2008) . In another study, it was shown that transcriptional activation of miR-34a contributes to the p53-mediated apoptosis (Raver-Shapira et al., 2007) .
The human miR-200 family consists of paralogs located on two chromosomal regions. Although miR-200b, miR-200a and miR-429 are located on chromosome 1p36, miR-200c and miR-141 are located on 12p13, and both regions are often deleted in several types of cancer (Sato et al., 2001; Bagchi and Mills, 2008) . Alternatively, based on the seed region (nucleotides 2-7), they can be divided into two sequence clusters: miR-200b, 200c and 429 (miR-200bc/429) , as well as miR-200a and 141 (miR-200a/141 ). The miR-200bc/429 cluster differs from the miR-200a/141 cluster with regard to only the fourth nucleotide (U to C) in the seed region. As it is commonly hypothesized that the seed region has a crucial role in miRNA direct targeting (Lewis et al., 2005) , in this paper we focus on the common features and differences of miR-200bc/429 and miR-200a/141 in breast cancer.
Reduced expression of the miR-200 family was recently shown to be associated with tumor progression (Baffa et al., 2009) . Epithelial-to-mesenchymal transition (EMT), a crucial process in the transformation of tumor cells into aggressive metastatic cancer cells, also seems to be tightly regulated by this family (Gregory et al., 2008) . In particular, all its members regulate transforming growth factor-beta (TGF-b)-induced EMT, as TGF-b stimulation reduces miR-200 levels and thus allows upregulation of the E-cadherin transcriptional repressors, zing finger E-box binding homeobox 1 (ZEB1) and Smad Interacting Protein 1, both of which are established targets of miR-200. However, there is no study examining the function of the miR-200 family in EGF-driven invasion, which has a central role in both normal breast development and cancer (Citri and Yarden, 2006) , and it is also not clear yet whether the two clusters have different regulatory effects.
Little is known about the role of the miR-200 family in cell growth and proliferation in breast cancer. Recently, Saydam et al. (2009) showed that miR-200a downregulation in meningioma subtypes of brain tumors promotes tumor growth by increasing Cyclin D1 and b-catenin in vitro and in vivo. Similarly, it was shown that the overexpression of miR-200a inhibits nasopharyngeal carcinoma cell growth, migration and invasion by targeting b-catenin and Smad interacting protein 1, whereas its knockdown stimulates these processes in these cells (Xia et al., 2010) . In contrast, it was reported that the human miR-200 family promotes cell growth when transfected into several cancer cell lines. In addition, they have shown that the miR-8-null fly, which is the Drosophila homolog of human miR-200 family, showed increased apoptosis in the brain and smaller body size compared with wild types (Hyun et al., 2009) . Controversial results among tumor types and the lack of breast cancer studies drove us to compare the roles of the two miR-200 clusters in breast cancer cell proliferation.
In this study, we show that the miR-200bc/429 cluster regulates cell viability, apoptosis, cell cycle progression and EGF-driven invasion in breast cancer cells with distinct patterns from the miR-200a/141 cluster. With miRNA target prediction algorithms and transcriptome profiling, we could identify 21 potential exclusive direct targets of miR-200bc/429, one of which is phospholipase C gamma 1 (PLCG1), the enzymatic activity of which is required for cell motility induced by EGF (Chen et al., 1994) , and for cell proliferation and survival (Markova et al., 2010) .
Results

Different targeting spectrums of two different clusters of the miR-200 family
The human miR-200 family can be divided into two clusters on the basis of seed-sequence similarity (miR200bc/429 cluster and miR-200a/141 cluster, Figure 1a) . We examined whether the single-nucleotide change between miR-200bc/429 and miR-200a/141 (U to C) is reflected to the targeting spectrum. Queries with three widely used miRNA target prediction tools (Figure 1b ) supported our hypothesis that although the two clusters have common predictions, there are far more mutually exclusive predicted targets for each cluster. However, it is unclear whether this difference will be reflected in the cancer cell phenotypes when the two clusters are expressed.
The miR-200bc/429 cluster reduces EGF-driven cell invasion stronger than the miR-200a/141 cluster in breast cancer To examine the role of miR-200 family in EGFdependent breast cancer cell invasion, we transfected the highly invasive MDA-MB-231 cell line with control mimic or miR-200 family mimics. Cells were then seeded in the presence of EGF, whereas fetal bovine serum was used as a chemoattractant in the trans-well assays. Overexpression of miR-200 family members reduced the invasion of cells compared with the mimic control (Figure 2 ), comparable to the effects in the TGF-binduced cell invasion (Gregory et al., 2008) . Interestingly, the effect of the miR-200bc/429 cluster was much more predominant than that of miR-200a/141 (P ¼ 8.7e-5). cluster, we examined whether the two clusters would have any effect on cell cycle progression or retardation. Therefore, we first performed the 7-amino-actinomycin D (7-AAD) cell cycle assay with miRNA mimics in MDA-MB-231 cells. As seen in Figure 4a , the 200a/141 cluster resulted in a higher G1 population compared with control, whereas the miR-200bc/429 cluster decreased the G1 population and increased the G2 population. In order to examine the differential effects of the two clusters on S-phase of the cell cycle in detail, we performed bromodeoxyuridine staining with pulse-labeling, and observed that although the miR-200bc/429 cluster did not significantly differ from the control (P ¼ 0.52), the 200a/141 cluster resulted in a reduction in S-phase population of the cells (P ¼ 0.027).
In order to elucidate the molecular changes responsible for the different effects of the two clusters on the cell cycle, we examined the changes in several cell cycle components either with reverse phase protein arrays (Sahin et al., 2007) (Figure 4c ), which could potentially explain the reduction of G1-phase after miR-200c mimic. Furthermore, we observed a significant decrease in CDK2 and increase in pCdc2 (T14) and pCdc25c (Ser 216), which refrain cells from transition from G2 to M phase, although we observed a strong increase in cyclin B1 and cyclin A levels in the miR-200c-transfected samples (Figures 4c and d ). In conclusion, the distinct patterns of the cell cycle progression when two clusters are expressed are in line with the differential regulation of cell cycle components. These results may indicate that differential targeting of the two clusters is reflected to different cell cycle progression profiles.
Target prediction algorithms and genome-wide expression profiling identify potential exclusive direct targets of the miR-200bc/429 cluster We propose that the distinct regulatory roles of miR200bc/429 and miR-200a/141 in breast cancer invasion, proliferation and cell cycle are caused by differential targets of the two clusters, especially those exclusive direct targets. As the miR-200bc/429 shows significant changes in all these phenotypes, we focused only on the genes that targeted by miR-200bc/429. First, we analyzed the predicted targets of the miR-200bc/429 cluster from the three algorithms, which identified 321 genes in common (Figure 5a ). Subsequently, we performed genome-wide mRNA microarray profiling with MDA-MB-231 cells transfected with all miR-200 Table 1) . The potential regulatory effects of miR-200bc/429 on these genes, therefore, could be, at least in part, accomplished by the mRNA cleavage mechanism.
Among these genes, PLCG1 is highly relevant in the breast cancer tumorigenesis and cancer development as it was reported to modulate EGF receptor-driven invasion (Li et al., 2009) and recently cell proliferation and apoptosis (Markova et al., 2010) . Western blot analysis validated that only the miR-200bc/429 cluster, but not the miR-200a/141 cluster, resulted in a reduction of PLCg1 protein expression (Figure 5d ). Therefore, we hypothesize that the potential regulation by direct targeting of miR-200bc/429 on PLCG1 contributes to the different regulatory effects of the two clusters on the phenotypes we examined. (Figures 6c and d) . As a complementary experiment, we transfected the miRNA hairpin inhibitors in MCF-7 cells and observed a significant increase in both mRNA and protein levels (Figures 6c and d) . The mRNA level regulation validates our hypothesis that the regulation of PLCG1 exclusively by miR-200bc/ 429 may, at least in part, be by an mRNA cleavage mechanism.
To determine whether the reduced expression of PLCg1 was because of the direct targeting of (Figure 6e , left). To further prove that this predicted target site is indeed responsible for the reduced luciferase activity, we cloned only the target site downstream of the luciferase open reading frame and measured the luciferase activity, where we also observed a significant reduction of luciferase activity, confirming the targeting of PLCG1 mRNA (Supplementary Figure 2a) . Furthermore, we observed an increase in the luciferase activity when the miR-200bc/429 was inhibited in MCF-7 cells (Figure 6e,  right) . Finally, we introduced mutations into the target site by changing four nucleotides within the seedmatching sequence. Disrupting the target site by mutagenesis resulted in a relative luciferase activity that was not significantly different from that obtained with control mimic (P ¼ 0.11, Supplementary Figure 2b) . To conclude, these results confirm our hypothesis that PLCG1 is a direct target of the miR-200bc/429 cluster, but not of miR-200a/141.
Targeting PLCG1 by miR-200bc/429 cluster contributes to the observed differential effects of two miR-200 family clusters Having established PLCG1 as a direct functional target of the miR-200bc/429 cluster, we examined the effect of loss of PLCG1 on cell viability, apoptosis and EGFdriven invasion using siRNAs. As can be seen from (Figure 7a) . Similarly, loss of PLCG1 moderately increased the caspase 3/7 activity, which reflects more apoptosis (Figure 7b ). Finally, we showed that loss of the PLCG1 gene with siRNAs would lead to the reduction of EGF-driven invasion in MDA-MB-231 cells in a ZEB1-pathway-independent manner (Figure 7c) . Furthermore, quantitative proteomics data indicated that ZEB1, known to be targeted by all five members and to have role in the reduction of TGF-bdriven invasion, was similarly targeted by all five members of the miR-200 family under EGF stimulus (Supplementary Figure 3) . These results indicate that the regulation by direct targeting of miR-200bc/429 contributes to the differential effects of the two clusters on breast cancer cell invasion, proliferation and apoptosis.
Discussion
In this study, we showed that two sequence clusters of human miR-200 family, miR-200bc/429 and miR-200a/ 141, have distinct profiles in EGF-dependent breast cancer cell invasion, proliferation and cell cycle progression. We have shown for the first time that all miR-200 family members regulate EGF-driven invasion, with the miR-200bc/429 cluster having stronger effects than the miR-200a/141 cluster. We have also shown that, although the miR-200a/141 cluster had no significant The role of miR-200 family in TGF-b-driven invasion by targeting ZEB1 and smad interacting protein 1 has been established (Gregory et al., 2008) . In this study, we showed that the expression of all miR-200 family members in MDA-MB-231 breast cancer cells also resulted in reduced EGF-driven invasion. However, the inhibitory effect of miR-200bc/429 is stronger than that of miR-200a/141 (Figure 2 ). In line with our study, Baffa et al. (2009) could show that miR-200c expression was significantly higher in primary tumors compared with metastases. Another study found that ductal mammary tumors expressed miR-200c at higher levels than sarcomatoid metaplastic tumors, where a significant correlation between expression of miR-200c and E-cadherin was detected for the two tumor types (Gregory et al., 2008) . We also showed that the PLCG1, which was suggested to be involved in EGF-induced cell motility (Chen et al., 1994) , is a direct target of the miR200bc/429 cluster ( Figure 6 ). Our results show the knockdown of PLCG1, which was reported to be increased in metastatic patients in comparison with primary breast tumors (Sala et al., 2008) , reduced EGFdriven cell invasion in a ZEB1-independent manner (Figure 7) .
Little is known about the involvement of miR-200 family in tumor progression in the context of cell proliferation. Even less is known about how different family members can affect tumor proliferation and/or whether there is any difference between their effects. In this study, we report that the miR-200bc/429 cluster, but not miR-200a/141, resulted in reduced viability of cells, as well as higher apoptosis induction (Figure 3) . The exclusive targeting of PLCG1 by miR-200bc/429 contributes to the observed distinct effect of this cluster on these phenotypes as it was quite recently shown that, in line with our study, suppression of PLCG1 resulted in inhibition of cell proliferation and enhanced apoptosis potentially by interaction of PLCG1 with the mTOR/ p70S6K pathway in chronic myeloid leukemia (Markova et al., 2010) . We observed that miR-200bc/429 decreased the G1 population of cells and increased the G2/M population compared with control (Figures 4a and b) . A strong increase in the phosphorylation of Cdc25C at the Ser-216 site, which prevents Cdc25C dual-specificity phosphatase from dephosphorylating and activating cyclin B1/Cdc2 (Peng et al., 1997) There is increasing evidence that EMT may contribute to the resistance to different therapies in cancer (Thomson et al., 2005; Yauch et al., 2005; Arumugam et al., 2009) . The miR-200 family, which regulates EMT, has also been reported in the sensitization of cancer cells to different drugs, for example, to the EGFR-targeting molecule gefitinib in bladder carcinoma (Adam et al., 2009) or to paclitaxel in breast, ovarian and endometrial cancers (Cochrane et al., 2010) . A current focus in drug discovery is to develop agents that target the cell cycle checkpoints, aiming at increasing or decreasing the amount of arrested cells at these points (reviewed in DiPaola, 2002) . We showed that miR-200bc/429 and miR-200a/141 members can lead to G2/M-or G1-arrest of the cell cycle, and therefore act as a tumor supressor. This observation could potentially be of therapeutic use as the overexpression of miR-200bc/429 in breast cancer may lead to higher apoptosis and less viability of the tumor cells. At the same time, our findings suggest that the drug sensitization role of miR-200 family may be explained not only by controlling the EMT, but also by leading to cell cycle arrest followed by apoptosis.
In conclusion, we have shown that two clusters of the miR-200 family differentially regulate EGF-driven breast cancer cell invasion, viability, apoptosis and cell cycle progression. Direct targeting of the key molecule PLCG1 in breast cancer by miR-200bc/429 contributes to this difference, and more comprehensive studies should be performed to elucidate the contribution of all mutually exclusive targets (or regulations by secondary effects of direct targeting) to the phenotypes caused by miR-200bc/429 and miR-200a/141 expression. We believe that the modulation of expression of miR-200 family members expression could be a potential approach for breast cancer treatment, highlighting the necessity for further studies.
Materials and methods
MiRNA target prediction
MiRNA-targeting predictions were queried in three target prediction databases: TargetScan (http://www.targetscan.org), PITA (http://genie.weizmann.ac.il/pubs/mir07) and DIANAmicroT (http://diana.pcbi.upenn.edu/cgi-bin/micro_t.cgi) with default parameters (for PITA the no-flanking top table was used, see the website for details).
Cell culture and serum/growth factor stimulation Two human breast cancer cell lines (MDA-MB-231 and MCF-7) were obtained from American Type Culture Collection (Manassas, VA, USA). Culturing media and supplements for the two cancer cell lines were described previously (Sahin et al., 2009) .
Transfection with siRNAs and miRNA mimics Cells were transfected with siRNAs targeting ZEB1 or PLCG1, purchased from Dharmacon (Lafayette, CO, USA). For each gene, four individual siRNAs were pooled (Supplementary Table 2 ). Allstar siRNA (Qiagen, Hilden, Germany) was used as non-silencing control. miRIDIAN miRNA mimics for 200 family, as well as the negative control, were from Dharmacon. siRNA transfection using Lipofectamine 2000 (Invitrogen, CA, USA) was carried out as previously described (Sahin et al., 2009) . siRNAs, miRNA mimics and miRNA hairpin inhibitors were transfected at final concentrations of 20, 25 and 100 nM, respectively.
Cell lysis and western blotting Preparation of protein lysates and western blotting was previously described (Sahin et al., 2009) . In all, 10 mg of protein was separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and exposed to primary antibodies (Supplementary Table 3 ). Horseradish peroxidase-conjugated secondary antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Reverse-phase protein array
Lysates were prepared as previously described (Sahin et al., 2009) . Five technical replicate spots were printed for every sample on nitrocellulose-coated glass slides (Grace Biolabs, Bent, OR, USA) using an Aushon 2470 contact printer (Aushon, Boston, MA, USA). Target protein-specific primary antibodies (Supplementary Table 4 ) were diluted to 1:300. Alexa680-labeled secondary antibodies (Invitrogen, Karlsruhe, Germany) were used and visualized using an Odyssey scanner (LI-COR, Lincoln, NE, USA). Signal intensities were quantified using Gene Pix Pro 5.0 (Molecular Device, Sunnyvale, CA, USA) and background corrected. Differences between miR-200a, miR-200c and control were identified for each antibody using Tukey's method applied to the ANOVA model. All the P-values reported have been adjusted for multiple testing using the Bonferroni method.
RNA isolation and mRNA/miRNA expression profiling Total RNA was isolated according to the manufacturer's protocol using the RNeasy Mini Kit (Qiagen). Sentrix HumanWG-6 arrays (Illumina, San Diego, CA, USA) were used for mRNA profiling. Quality control of total RNA, as well as labeling and hybridization, was performed at the DKFZ microarray core facility. Expression profiling data were normalized with the variance stabilization transformation algorithm (Huber et al., 2002) and analyzed using the Bioconductor limma package (Smyth, 2004) .
Quantitative RT-PCR of mRNA and miRNAs cDNA synthesis was carried out with the Revert Aid H Minus First Strand cDNA Synthesis Kit (Fermentas St Leon-Rot, Germany), and using 10 ng of total RNA. The quantitative reverse transcriptase-PCR reactions for target genes and housekeeping genes ACTB, HPRT and TFRC were performed with an ABI Prism 7900HT Sequence Detection System (Applied Biosystems, Weiterstadt, Germany) using probes from the Universal Probe Library (Roche, Penzberg, Germany). Oligonucleotide primers were synthesized at MWG (Ebersberg, Germany). Sequences of primers and the respective UPL probe numbers are given (Supplementary Table 5 ). Reverse transcription of miRNAs was performed using the TaqMan MicroRNA Reverse Transcription kit (Applied Biosystems) with 4 ng total RNA and thereafter, using the miRNA TaqMan Assay (Applied Biosystems). RNU44 and RNU48 were used as housekeeping controls. Data were analyzed using the Delta-Delta-Ct algorithm (Livak and Schmittgen, 2001 ) (Bioconductor ddCt package).
Plasmid construction, mutagenesis and luciferase assay The 3 0 -UTR of PLCG1 gene was amplified by PCR using human genomic DNA (Supplementary Table 6 ) and cloned downstream of the luciferase open reading frame using the NheI and XhoI sites in the pLuc vector. Four point mutations were generated within the predicted target site of PLCG1 3 0 -UTR using the QuikChange XL site-directed mutagenesis kit (Stratagene, La Jolla, CA, USA) according to the manufacturer's instruction. For the luciferase assay, cells were transfected with 25 mM of miRNAs and the luciferase vector together with the pMIR-REPORT b-gal vector (Ambion, Austin, TX, USA). Luciferase and b-gal activities were measured using the Dual-Light System (Applied Biosystems, Foster City, CA, USA), following the manufacturer's instructions. Relative luciferase activity was determined by the ratio of luciferase signal intensity to that of b-gal for normalization. The average and standard deviations of the ratio were estimated by the Delta-method (Bioconductor ratioAssay, under review).
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